Shufeng Chen Selected Research

Shufeng Chen Research Topics

Disease

17	Hypertension (High Blood Pressure) 12/2021 - 11/2004
10	Essential Hypertension 01/2013 - 11/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 11/2006
6	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022 - 12/2017
6	Coronary Disease (Coronary Heart Disease) 01/2020 - 04/2006
4	Atherosclerosis 02/2022 - 02/2009
3	Myocardial Infarction 01/2018 - 11/2006
3	Type 2 Diabetes Mellitus (MODY) 01/2015 - 11/2004
2	Obesity 10/2021 - 11/2004
2	Overweight 10/2021 - 05/2014
2	Genetic Risk Score 12/2018 - 02/2016
1	Atherosclerotic Plaque (Atheroma) 02/2022
1	Heart Diseases (Heart Disease) 12/2021
1	COVID-19 06/2021
1	Neointima 01/2021
1	Lung Neoplasms (Lung Cancer) 12/2020
1	Abdominal Obesity 01/2018
1	Hyperlipidemias (Hyperlipidemia) 02/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2016
1	Unstable Angina 01/2015
1	Acute Coronary Syndrome 01/2015
1	Vascular Remodeling 01/2014
1	Inflammation (Inflammations) 07/2009
1	Tuberculosis (Tuberculoses) 07/2008

Drug/Important Bio-Agent (IBA)

5	Particulate MatterIBA 10/2021 - 01/2020
4	LipidsIBA 12/2021 - 11/2004
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 08/2012 - 12/2010
2	SodiumIBA 12/2021 - 12/2018
2	SaltsIBA 12/2021 - 01/2018
2	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Long Noncoding RNAIBA 01/2019 - 01/2018
2	C-Reactive ProteinIBA 05/2014 - 07/2009
2	Fibrillin-1IBA 01/2014 - 06/2011
1	CytokinesIBA 02/2022
1	MicroRNAs (MicroRNA)IBA 02/2022
1	CholesterolIBA 02/2022
1	Biological ProductsIBA 12/2021
1	Pharmaceutical PreparationsIBA 12/2021
1	LDL CholesterolIBA 12/2021
1	VaccinesIBA 06/2021
1	N-methyladenosineIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Circular RNAIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	HDL CholesterolIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	serum-glucocorticoid regulated kinaseIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 11/2016
1	Apolipoproteins E (ApoE)IBA 02/2016
1	Genetic Markers (Genetic Marker)IBA 10/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Sirtuin 1IBA 01/2015
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2014
1	GTP-Binding Proteins (G-Protein)IBA 05/2014
1	AdrenomedullinIBA 01/2013
1	Factor VII (Proconvertin)IBA 08/2011
1	Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA 02/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2009
1	Kininogens (Kininogen)IBA 03/2009
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 02/2009
1	EnzymesIBA 09/2008
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 09/2008
1	CatecholaminesIBA 09/2008
1	vasectrin II (VS II)IBA 06/2008
1	Tissue Kallikreins (Tissue Kallikrein)IBA 09/2007
1	DNA (Deoxyribonucleic Acid)IBA 09/2007
1	renalaseIBA 08/2007
1	Plasma KallikreinIBA 05/2007
1	Peptides (Polypeptides)IBA 05/2007
1	KininsIBA 05/2007
1	Serine Proteases (Serine Protease)IBA 05/2007
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2006
1	G-Protein-Coupled Receptor Kinase 4IBA 11/2006
1	Adrenergic Receptors (Adrenergic Receptor)IBA 06/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2006
1	PPAR gammaIBA 11/2004

Therapy/Procedure

2	Therapeutics 11/2021 - 07/2008